Calpain: a death protein that mediates progression of liver injury

Harihara M Mehendale1, Pallavi B Limaye

  • 1Department of Toxicology, School of Pharmacy, College of Health Sciences, The University of Louisiana at Monroe, 700 University Avenue, Monroe, LA 71209 USA. mehendale@ulm.edu

Insights

Calpain, a calcium-regulated protease, plays a role in liver injury. Inhibiting calpain can prevent toxicant-induced liver damage and acute liver failure, offering a new therapeutic strategy.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pathology

Background:

  • Calpain is a calcium-regulated cysteine protease involved in essential cellular functions.
  • Dysregulation of calpain is linked to various pathologies, including neurodegenerative diseases and diabetes.
  • Recent research highlights calpain's role in toxicant-induced liver injury.

Purpose of the Study:

  • To investigate the role of extracellular calpain in the progression of toxicant-induced liver damage.
  • To evaluate the therapeutic potential of calpain inhibitors in mitigating liver injury.

Main Methods:

  • The study likely involved experimental models of toxicant-induced liver injury.
  • Assessment of calpain activity in the extracellular milieu of damaged hepatocytes.
  • Evaluation of the efficacy of calpain inhibitors in preventing liver damage progression.

Main Results:

  • Extracellular calpain, released from necrotic hepatocytes, contributes to the progression of liver injury.
  • Calpain inhibitors significantly reduced the severity of toxicant-induced liver damage.
  • Calpain inhibition prevented acute liver failure and reduced mortality in animal models.

Conclusions:

  • Extracellular calpain is a key mediator in the pathogenesis of toxicant-induced liver injury.
  • Calpain inhibitors represent a promising therapeutic strategy for acute liver failure and toxicant-induced toxicities.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...